Download | < Back |
19 Jan 2022 | |
In continuation to our disclosure dated- 05-July-2021, Ref. No. ANG/21-22/BSE-12, we hereby affirm that the Company will be able to surpass the targeted sales of Rs. 350 crs. in Financial Year 2021-22 with healthy bottom line. | |
View all announcements for ANG Lifesciences India Ltd | Source: BSE India |